Related content

Lymphopenia following the completion of first-line therapy predicts early relapse in patients with diffuse large B cell lymphoma

By Aoki Tomohiro   Nishiyama Takahiro   Imahashi Nobuhiko   Kitamura Kunio  

Annals of Hematology, Vol. 91, Iss. 3, 2012-03 ,pp. : 375-382

Springer Publishing Company

Access to resources Recommend Favorite

Clonal expanded TRA and TRB subfamily T cells in peripheral blood from patients with diffuse large B-cell lymphoma

By Tan Huo   Ye Jingmei   Luo Xiaodan   Chen Shaohua   Yin Qingsong   Yang Lijian   Li Yangqiu  

Hematology, Vol. 15, Iss. 2, 2010-04 ,pp. : 81-87

Maney Publishing

Access to resources Recommend Favorite

Differences in outcome for consecutive patients with diffuse large B-cell lymphoma before and after the advent of rituximab: a single-center experience

By Okamoto Akinao   Yanada Masamitsu   Inaguma Yoko   Tokuda Masutaka   Morishima Satoko   Kanie Tadaharu   Yamamoto Yukiya   Tsuzuki Motohiro   Akatsuka Yoshiki   Mizuta Shuichi   Okamoto Masataka   Emi Nobuhiko  

Hematology, Vol. 18, Iss. 2, 2013-03 ,pp. : 74-80

Maney Publishing

Access to resources Recommend Favorite

Importance of maintaining the relative dose intensity of CHOP-like regimens combined with rituximab in patients with diffuse large B-cell lymphoma

By Hirakawa Tsuneaki   Yamaguchi Hiroki   Yokose Norio   Gomi Seiji   Inokuchi Koiti   Dan Kazuo  

Annals of Hematology, Vol. 89, Iss. 9, 2010-09 ,pp. : 897-904

Springer Publishing Company

Access to resources Recommend Favorite

Characterization of conserved CDR3 sequence of TCR α- and β-chain genes in peripheral blood T-cells from patients with diffuse large B-cell lymphoma

By Yin Qingsong   Tan Huo   Chen Shaohua   Yang Lijian   Ye Jingmei   Li Yangqiu  

Hematology, Vol. 15, Iss. 1, 2010-02 ,pp. : 48-57

Maney Publishing

Access to resources Recommend Favorite